News & Events

NASHUA, NH, and CHICAGO, IL, February 26, 2025 — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven ultrasound cancer diagnosis, today announced a strategic reseller partnership to deliver a comprehensive, multi-modality AI suite for breast cancer detection….

NASHUA, N.H. – February 19, 2025 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that five clinical presentations and abstracts highlighting the Company’s advancements in…

iCAD to Participate in the BTIG at Snowbird: 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, NH., January 27, 2025 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader on a mission to create a world where cancer can’t hide by…

http://www.jtradiologie.com

The Imaging Wire

Oncology Data Advisor – Podcast

Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.

Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.

Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.

Dr. Vautrin, a user of iCAD’s ProFound AI solution for 2D and 3D mammography for nearly two years, shares her experience through a series of clinical cases where the AI-provided insights were crucial in detecting cancer in her patients.

Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris

Utilisatrice de la solution ProFound IA d’iCAD pour les mammographies 2D et 3D depuis près de deux ans, le Dr Vautrin partage son retour d’expérience au travers d’une dizaine de cas cliniques pour lesquels les informations fournies par l’IA se sont avérées déterminantes pour détecter des cancers chez ses patientes.